Study and results of a laparoscopic biliopancreatic diversion modality for diabetes type 2 treatment in patients with a BMI between 30 and 35: a randomized prospective clinical trial

Aragon Institute of Health Sciences [Instituto Aragonés de Ciencias de la Salud] (Spain)0 个研究点目标入组 74 人开始时间: 2012年2月20日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Patients diagnosed with type 2 diabetes
•2. Between 18 and 60 years old
•3. Body mass index (BMI) between 30 and 35
•4. Less than 10 years of illness evolution
•5. Subject to medical treatment (oral antidiabetics, and/or insulin) and without enough control
•6. More than 2 years of medical treatment and adequate pancreatic reserve (haemoglobin glycosylated determination with a result of more than 7)

•1. Positive anti glutamic acid decarboxylase (GAD) antibodies
•2. Patients diagnosed with type 2 diabetes controlled with one or two oral antidiabetics, preanesthetic evaluation between 4 or 5 Anesthetic Society of America criteria values (ASA)
•3. Laparoscopic and surgery general contraindications

发起方

Aragon Institute of Health Sciences [Instituto Aragonés de Ciencias de la Salud] (Spain)